Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia evolution and overall survival (OS). In this study,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Cancer J
Asıl Yazarlar: Hou, Hsin-An, Tsai, Cheng-Hong, Lin, Chien-Chin, Chou, Wen-Chien, Kuo, Yuan-Yeh, Liu, Chieh-Yu, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Liao, Xiu-Wen, Lin, Liang-In, Yao, Ming, Tang, Jih-Luh, Tien, Hwei-Fang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://ncbi.nlm.nih.gov/pubmed/29618722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0074-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller